Alterations in the Abundance and Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the Colonic Mucosa of Inflammatory Bowel Disease Subjects
Изменения обилия и совместной встречаемости Akkermansia muciniphila и Faecalibacterium prausnitzii в слизистой оболочке толстой кишки пациентов с воспалительными заболеваниями кишечника
2018-09-07
SCID: 54.1/ufg3ue8y
Discuss with AI
Akkermansia muciniphilaFaecalibacterium prausnitziicolonic mucosainflammatory bowel diseasequantitative PCR
Figures from the paper
Abstract (AI)
Akkermansia muciniphila and Faecalibacterium prausnitzii, cohabitants in the intestinal mucosa, are considered members of a healthy microbiota and reduction of both species occurs in several intestinal disorders, including inflammatory bowel disease. Little is known however about a possible link between the reduction in quantity of these species, and in which circumstances this may occur. This study aims to determine the abundances and co-occurrence of the two species in order to elucidate conditions that may compromise their presence in the gut. Loads of A. muciniphila, total F. prausnitzii (16S rRNA gene copies) and its two phylogroup were determined by quantitative polymerase chain reaction targeting specific regions of the 16S rRNA gene in colonic biopsies from 17 healthy controls (H), 23 patients with ulcerative colitis (UC) and 31 patients with Crohn’s disease (CD). Data were normalised to total bacterial 16S rRNA gene copies in the same sample. Prevalence, relative abundances and correlation analyses were performed according to type of disease and considering relevant clinical characteristics of patients such as IBD location, age of disease onset, CD behaviour, current medication and activity status. Co-occurrence of both species was found in 29% of H, 65% of UC and 29% of CD. Lower levels of total F. prausnitzii and phylogroups were found in subjects with CD, compared with H subjects (P≤0.044). In contrast, no differences were found with the regard to A. muciniphila abundance across different disease states,but CD patients with disease onset below 16 years of age featured a marked depletion of this species. In CD patients, correlation between A. muciniphila and total F. prausnitzii (ρ=0.362, P=0.045) was observed, and particularly in those with non-stricturing, non-penetrating disease behaviour and under moderate immunosuppressants therapy. Altogether, this study revealed that co-occurrence of both species differs between disease status. In addition, IBD patients featured a reduction of F. prausnitzii but similar loads of A. muciniphila when compared to H subjects, with the exception of those with early onset CD. Depletion of A. muciniphila in this subgroup of subjects suggests that it could be a potential biomarker to assist in paediatric CD diagnosis.
Key Findings
1
A. muciniphila abundance did not differ overall among healthy controls, ulcerative colitis, and Crohn’s disease, but was markedly depleted in Crohn’s disease diagnosed before age 16.
2
Co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii differed by disease status: 29% in healthy controls, 65% in ulcerative colitis, and 29% in Crohn’s disease.
3
In Crohn’s disease, A. muciniphila abundance correlated positively with total F. prausnitzii abundance (ρ=0.362, P=0.045), especially in non-stricturing, non-penetrating disease and during moderate immunosuppressant therapy.
4
Total F. prausnitzii and its two phylogroups were significantly less abundant in Crohn’s disease than in healthy controls (P≤0.044).
Research Object
Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of healthy controls and patients with ulcerative colitis or Crohn’s disease
Research Subject
Their abundance, prevalence, co-occurrence, and correlations in relation to inflammatory bowel disease status and clinical characteristics
Publication Details
Publication Date
2018-09-07
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest